Leveraging Development Strengths Drives Therapies to Market

AbbVie Treatment for Ovarian, Other Gynecological Cancers Approved by MHRA

While little information is known about this particular case, its possible implications are far-reaching.

ICH Q12 and Post-Approval Changes–Less than Satisfactory State of Affairs

Mirvetuximab soravtansine, brand name Elahere, is the first licensed treatment for women with platinum-resistant ovarian cancer in the UK in more than 10 years.

Cancer Question | Image Credit: ©freshidea - Stock.adobe.com

Siegfried Schmitt

RFK Jr.'s Removal of Thimerosal from Flu Vaccines Spurs Opposing Reactions

Speedier implementation of the Post-Approval Change Management Protocol is essential for it to have a positive effect on supply security, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.

Mercury. Element 80 of the periodic table of chemical elements. | Image Credit: © N. Elkha - stock.adobe.com

Potential Effects of MHRA’s New Decentralized Manufacture Regulations

Following an overhaul at ACIP, the HHS secretary took the advice of the committee’s new members, saying he was acting on guidance that dated back to 1999.

Pharmaceutical Optical Ampoule / Vial Inspection Machine. 3d illustration | Image Credit: © unlimit3d - stock.adobe.com

FDA Extends Review Period for GSK’s Blenrep

Manufacturing sites and a control site will work together in a hub-and-spoke model that has key differences from conventional manufacturing operations.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Susan Haigney

FDA Investigates Pediatric Elevidys Death: 5 Things to Know

The agency has extended the review period for GSK’s biologics license application for belantamab mafodotin-blmf for the treatment of relapsed/refractory multiple myeloma.

Related Content

AbbVie Treatment for Ovarian, Other Gynecological Cancers Approved by MHRA

While little information is known about this particular case, its possible implications are far-reaching.

ICH Q12 and Post-Approval Changes–Less than Satisfactory State of Affairs

Mirvetuximab soravtansine, brand name Elahere, is the first licensed treatment for women with platinum-resistant ovarian cancer in the UK in more than 10 years.

Siegfried Schmitt

RFK Jr.'s Removal of Thimerosal from Flu Vaccines Spurs Opposing Reactions

Potential Effects of MHRA’s New Decentralized Manufacture Regulations

Following an overhaul at ACIP, the HHS secretary took the advice of the committee’s new members, saying he was acting on guidance that dated back to 1999.

FDA Extends Review Period for GSK’s Blenrep

Manufacturing sites and a control site will work together in a hub-and-spoke model that has key differences from conventional manufacturing operations.

Susan Haigney